The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling. - Wikidata - wikimedia - TriplyDB

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.

http://www.wikidata.org/entity/Q41004843

about

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.Development of allosteric modulators of GPCRs for treatment of CNS disorders The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies.The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.New drugs in psychiatry: focus on new pharmacological targets.Leading compounds for the validation of animal models of psychopathology.Qualification of LSP1-2111 as a Brain Penetrant Group III Metabotropic Glutamate Receptor Orthosteric Agonist.Determination of the absolute configuration of phosphinic analogues of glutamate

P2860

Q34125116-62C5E317-A4D7-4632-A8FE-C0C0FE9B20C5 Q34373958-907D28D0-CBD8-4B9A-82EB-3F0A4D94AC4A Q34798345-E3F5FAB2-E2AA-468A-8C9F-B2885D917B97 Q37122707-2435C9D1-31EC-4681-B600-593434386E07 Q37172877-6EDA2D41-348F-41AD-BED8-5FE8E3148AE9 Q37730207-E8829420-FBB3-49BD-AEF1-0347828512F9 Q38128733-E9F10BE1-AE42-4FDF-930F-359DF5CC1DE3 Q39782221-1A5B5F1E-4B65-40AC-9699-AFAD0CE9045F Q58878103-188FBB36-EE0D-4000-8E0C-A4BB5CDF6E7A

P2860

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.

http://www.wikidata.org/entity/Q41004843

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The antipsychotic-like effects ...... 1, involves 5-HT₁A signalling.

@en

type

label

The antipsychotic-like effects ...... 1, involves 5-HT₁A signalling.

@en

prefLabel

The antipsychotic-like effects ...... 1, involves 5-HT₁A signalling.

@en

P1433

Q41004843-5E18AA80-FB49-4F0E-8B46-D376526C4D19

P1476

Q41004843-BE02703E-DEB7-4BED-96C4-5362D2329D3C

P2093

Q41004843-37298741-CA84-4BD0-BF1F-F8E15C4B9F95

Q41004843-4F581E19-ED03-4A02-B16A-6E609DE556C5

Q41004843-BAF00050-2F90-4A77-A6D4-762EA2CB3756

P2860

Q41004843-012A7E8C-B447-484E-AC38-ECEE158238D5

Q41004843-01A4B189-4A5A-4F15-B5EF-FC0AADC58657

Q41004843-0D57C671-2302-4250-B169-A15A79D32DB8

Q41004843-117D7C82-139E-4523-B29C-F5AEF61BA767

Q41004843-1E2CDE9F-436F-446B-90EC-026C303324C7

Q41004843-1EF507B1-5C34-4B3D-97E5-BEEE9DAFED45

Q41004843-20169856-FAD7-4583-A127-DC892615D691

Q41004843-2408CB96-C363-4C28-AE86-0D51BD83157B

Q41004843-24149DE5-40B0-40B5-9CB5-A2CAA98F867C

Q41004843-27D5A3E0-1862-4C4D-977F-E02403BA160F

P2888

Q41004843-2A9C3F87-DD8C-4378-83D5-1B356DABF93D

P304

Q41004843-4D91B32B-1A7A-49DE-8352-D012FD7DE9CF

P31

Q41004843-C5552944-96A6-4585-B23E-F7ECB3E115E5

P356

Q41004843-94E30964-21AC-4EE0-9FE2-865E4683FA62

P433

Q41004843-713280C3-9028-4E25-9E5A-E2170E04C687

P478

Q41004843-7434BF07-1F53-4CC6-B81B-053F219A5659

P50

Q41004843-0D37B034-DC74-4180-ADC8-6DB96C78A878

Q41004843-CBEBAF03-A410-4A02-9D7C-8DEAE0F8A17F

Q41004843-E3926FA5-3D2F-4E9B-A16A-D0F0292D3716

Q41004843-F1DF65BF-61ED-408D-8025-788400D0267A

P577

Q41004843-C025FB7B-D6E3-4851-82CC-519DA93391CD

P5875

Q41004843-72912768-B4B2-4B0F-B070-1DF031365AA5

P6179

Q41004843-EFF06C57-032F-491E-90C8-5846B1B9D7E8

P698

Q41004843-D34E3D0C-28B1-4FCA-AD99-A6C174FA9F2C

P932

Q41004843-4D8CB138-3DA3-4FD9-BEDF-952CD0336418

P356

S00213-013-3005-0

P1433

Psychopharmacology

P1476

The antipsychotic-like effects ...... 1, involves 5-HT₁A signalling.

@en

P2093

Anna Sławińska

http://www.w3.org/2001/XMLSchema#string

Francine C Acher

http://www.w3.org/2001/XMLSchema#string

Magdalena Lasoń-Tyburkiewicz

http://www.w3.org/2001/XMLSchema#string

P2860

The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Identification of a serotonin/glutamate receptor complex implicated in psychosis

A review of central 5-HT receptors and their function

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex

Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agon

Regulation of neurotransmitter release by metabotropic glutamate receptors

A search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices--immunohistochemical studies

P2888

s00213-013-3005-0

P304

711-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-013-3005-0

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

227

http://www.w3.org/2001/XMLSchema#string

P50

Joanna Wierońska

P577

2013-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235895414

http://www.w3.org/2001/XMLSchema#string

P6179

1002719037

http://www.w3.org/2001/XMLSchema#string

P698

23474845

http://www.w3.org/2001/XMLSchema#string

P932

3663209

http://www.w3.org/2001/XMLSchema#string